News

Tiziana Life Sciences Secures Up to $10 Million in Offering

Tiziana Life Sciences Secures Up to $10 Million in Offering

Tiziana Life Sciences Secures Up to $10 Million in Offering

Tiziana Life Sciences, Ltd. (NASDAQ: TLSA), a prominent biotechnology firm known for its innovative immunomodulation therapies, has recently made significant strides by entering into a securities purchase agreement. This agreement involves the sale of 5,263,158 common shares at a price of $0.95 each, leading to expected gross proceeds of approximately $5 million.

Details of the Offering

The offering is set to close on a specific date, pending the usual closing conditions. In addition to the initial offering, there is also an option provided to investors, allowing them to purchase an additional 5,263,158 common shares at the same price within 75 days post-closing. This option could potentially generate an additional $5 million, reflecting the company's confidence in its future prospects.

Utilization of Proceeds

The net proceeds from this offering are aimed at advancing Tiziana's Phase 2a clinical trial. This trial will focus on the intranasal administration of foralumab, targeted at patients with non-active secondary progressive multiple sclerosis. Additionally, these funds are intended to expedite the clinical development of foralumab for Alzheimer's disease, along with supporting the exploration of other indications and general corporate needs.

About Tiziana Life Sciences

As a clinical-stage biopharmaceutical entity, Tiziana Life Sciences is dedicated to the development of groundbreaking therapies. They are particularly recognized for their innovative methods of drug delivery that aim to enhance both the efficacy and safety of treatment options compared to traditional intravenous routes. Their flagship candidate, intranasal foralumab, has showcased a promising safety profile and encouraging clinical responses in earlier trials.

A Unique Approach to Immunotherapy

Tiziana's pioneering approach involves the use of nasal administration which has the potential to revolutionize how patients receive immunotherapy. This method not only improves the ease of administration but also aims to enhance treatment outcomes. The company holds patents for this technology and is actively pursuing additional applications within this space.

Contact Information

For inquiries, Tiziana Life Sciences can be reached at the following contact:

Tiziana Life Sciences Ltd
Paul Spencer, Business Development and Investor Relations
+44 (0) 207 495 2379
Email: info@tizianalifesciences.com

Frequently Asked Questions

What is the purpose of Tiziana's recent offering?

The recent offering aims to raise funds primarily for clinical trials and the development of their lead therapeutic candidate, intranasal foralumab.

How much money is Tiziana hoping to raise?

Tiziana is looking to raise approximately $10 million through this offering, with $5 million initially and an option for an additional $5 million.

What clinical trial is Tiziana pursuing?

Tiziana is advancing a Phase 2a clinical trial focused on the use of intranasal foralumab for treating patients with non-active secondary progressive multiple sclerosis.

What are the benefits of Tiziana's drug delivery method?

The nasal delivery method is designed to improve the efficacy, safety, and tolerability of immunotherapy compared to traditional intravenous methods.

Who can I contact for more information about Tiziana Life Sciences?

You can reach out to Paul Spencer at Tiziana Life Sciences through the provided contact information for further inquiries.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

SolidRun Unveils Unified Platform for Industrial AI

Updated Category News Views 93

SolidRun Steers the Future of Industrial AI SolidRun's newest venture appears as bold as a bull in a china shop, shaking up the industrial AI market with a comprehensive product line integrating NXP's i.MX 95 System-on-Modules and NVIDIA's Holoscan. What's the big deal? They're connecting the dots across the entire tech stack under one roof, flattening some hills that...

Continue Reading
Replit Wins 2026 Microsoft Startup Partner Award

Updated Category News Views 51

Replit's Triumph in the Microsoft Ecosystem If there's one thing you come to expect from this dizzying dance of technology and business, it's that standout players get their due when they push the envelope. Replit just snagged a gleaming accolade by being named Microsoft's 2026 Partner of the Year for Startups. That's a hefty badge, especially coming from a giant like...

Continue Reading
NYSE Salutes Veterans and Shares Market Insights

Updated Category News Views 110

Honoring Veterans at the NYSE It's not every day you see the hustle and bustle of the NYSE pause for a moment of reflection, but Veterans Day is one of those rare occasions. Before traders dive into the chaos of buying and selling, there's a solemn recognition of those who've soldiered on for our freedoms—a refreshing pause, if you ask me. As Brigadier General Matthew...

Continue Reading
Flooring Market to Hit $255 Billion by 2031: What's Driving This?

Updated Category News Views 40

The Construction Wave Lifts Flooring High Feels like flooring is set to ride a massive wave in the construction boom—an ambitious $255.35 billion splash by 2031. It's not the kind of climb you see out of nowhere; it’s paved by a 4.17% CAGR from 2026. This growth screams opportunity for anyone knee-deep in the construction game, where every square inch needs flooring....

Continue Reading
Frontera Energy: Solid Gains Amid Strategic Expansions

Updated Category News Views 0

Thriving in a Complex Energy World You know, for Frontera Energy Corporation, it's not just about tossing around tanker loads of cash—it’s about working those numbers into something real. Their Q3 2026 gives us a peep into how they’re keeping the hot iron pressed against opportunity. With a net income of $11.7 million and adjusted EBITDA jumping 16% to top $34.8...

Continue Reading
LINE-X Seeks Veterans to Propel Franchise Growth

Updated Category News Views 109

If you've ever wondered about the intersection of military discipline and entrepreneurial spirit, LINE-X is handing veterans the keys, quite literally. With a nod to leathernecks and GIs, they're slashing their franchise fee by 25% for U.S. veterans aiming to trade sergeants' stripes for business clout. Franchising for Veterans: A Tailored Offer So, the word on the street...

Continue Reading
Honeywell Aerospace Faces Class Action Suit Deadline

Updated Category News Views 22

Investors Grapple with Bitter Pill: The HONA Legal Saga Alright, let's dive headfirst into the latest headache for Honeywell Aerospace Inc. (NASDAQ: HONA) shareholders. Earlier this year, HONA found itself in hot water over allegations linked to cybersecurity blunders and misleading statements. If you've invested in this company anytime from June 29 to September 1, 2026,...

Continue Reading
Premium Guard Inc. Secures 2027 Top Supplier Honor

Updated Category News Views 62

This ain't your everyday pat on the back—when Premium Guard Inc. (PGI) snagged the 2027 Top Supplier title from MEMA Aftermarket Suppliers and aftermarketNews, it was a nod to their hustle in the wild world of automotive. Yeah, the guys in Memphis are overachievers, consistently nudging the envelope of car parts. Why Premium Guard Stands Out Let’s be real, it’s not...

Continue Reading
Insulin Delivery Devices: A Billion-Dollar Surge

Updated Category News Views 25

When's the last time you saw a medical device market promising a $10 billion leap in under five years? Yeah, the insulin delivery devices market's got that kind of upside, projected to skyrocket from $16.92 billion in 2026 to a whopping $26.37 billion by 2031. That's a 9.3% annual growth rate. The numbers and the stakes are both staggering. Regional and Segment Leaders...

Continue Reading
Aristocrat's FY26 Delivers Momentum for FY27 Gains

Updated Category News Views 48

FY26 Performance Worth Noting I'm telling you, Aristocrat is coming out swinging with their FY26 results—nothing short of mighty impressive. The company clocked a solid fiscal performance, registering a revenue growth spurt worth 4% in constant currency. Even while global markets are a swirling mess, they've found ways to take market share, proving they're more than...

Continue Reading

Top 5 Most Recently Viewed Articles

Trixo Fund: A Deep Dive into the Investment Platform Redefining Online Wealth Building

Updated Category Personal Finance Views 1417

Trixo Fund isn't just another name floating around the crowded world of investment platforms. It's a system built with the modern investor in mind—those who are looking not only for growth but also for simplicity, transparency, and innovation. With dozens of platforms making lofty promises, it takes more than buzzwords to stand out. Trixo Fund achieves this by...

Continue Reading
Exploring China's Dominance in Global AI Research Landscape

Updated Category News Views 342

China's Growing Influence in AI Research China is rapidly establishing itself as a leader in artificial intelligence (AI) research. Recent analyses indicate that the nation is making significant strides, not just in the volume of research but also in the impact and attention it receives globally. According to a compelling report by renowned research technology company...

Continue Reading
MoneyGram Enhances European Reach through Plaid Partnership

Updated Category News Views 405

Expansion of MoneyGram and Plaid Collaboration in Europe MoneyGram has recently taken significant steps by expanding its partnership with Plaid, introducing pay-by-bank capabilities to customers in Europe. This follows a successful launch in the U.S., demonstrating a commitment to enhancing customer experiences in international payments. Benefits for European Customers...

Continue Reading
Mandalay Resources Finalizes Major Acquisition with Alkane

Updated Category News Views 176

Mandalay Resources Secures Approval for Alkane Acquisition The recent announcement from Mandalay Resources Corporation marks a significant milestone for the company. The Supreme Court of British Columbia has granted a final order approving the arrangement wherein Alkane Resources Limited will acquire all outstanding common shares of Mandalay Resources. With this strategic...

Continue Reading
KBS Builders Secures $3.2 Million Contract for Townhouses

Updated Category News Views 252

KBS Builders Secures Major Contract for New Housing Project Star Equity Holdings, Inc., a diversified holding company, has unveiled exciting news. Its subsidiary, KBS Builders, Inc., has recently inked a contract worth $3.2 million aimed at developing a multifamily housing project. This contract is a significant achievement for KBS and highlights its expanding footprint...

Continue Reading